These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29630902)

  • 21. Recent Advances in Drug Repurposing for Parkinson's Disease.
    Chen X; Gumina G; Virga KG
    Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
    Sayeed I; Stein DG
    Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway.
    Zhang M; Wu J; Ding H; Wu W; Xiao G
    Neurocrit Care; 2017 Apr; 26(2):292-300. PubMed ID: 27995513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Progesterone on Preclinical Animal Models of Traumatic Brain Injury: Systematic Review and Meta-analysis.
    Nasre-Nasser RG; Severo MMR; Pires GN; Hort MA; Arbo BD
    Mol Neurobiol; 2022 Oct; 59(10):6341-6362. PubMed ID: 35922729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury.
    Meyfroidt G; Taccone FS
    Minerva Anestesiol; 2016 Apr; 82(4):486-91. PubMed ID: 26126980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Validation of the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury: Prognostic Models for Traumatic Brain Injury on the Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries Trial.
    Sun H; Lingsma HF; Steyerberg EW; Maas AI
    J Neurotrauma; 2016 Aug; 33(16):1535-43. PubMed ID: 26652051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.
    Howard RB; Sayeed I; Stein DG
    J Neurotrauma; 2017 Jun; 34(11):1915-1918. PubMed ID: 26370183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
    Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone Exacerbates Short-Term Effects of Traumatic Brain Injury on Supragranular Responses in Sensory Cortex and Over-Excites Infragranular Responses in the Long Term.
    Allitt BJ; Johnstone VP; Richards K; Yan EB; Rajan R
    J Neurotrauma; 2016 Feb; 33(4):375-89. PubMed ID: 26258958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the neuroprotective role of vitamin D in traumatic brain injury with implications for supplementation post-concussion.
    Lawrence DW; Sharma B
    Brain Inj; 2016; 30(8):960-8. PubMed ID: 27185224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Potential of Neurosteroids for CNS Disorders.
    Reddy DS; Estes WA
    Trends Pharmacol Sci; 2016 Jul; 37(7):543-561. PubMed ID: 27156439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapies negating neuroinflammation after brain trauma.
    Hellewell S; Semple BD; Morganti-Kossmann MC
    Brain Res; 2016 Jun; 1640(Pt A):36-56. PubMed ID: 26740405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
    Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
    Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision.
    Kochanek PM; Jackson TC; Jha RM; Clark RSB; Okonkwo DO; Bayır H; Poloyac SM; Wagner AK; Empey PE; Conley YP; Bell MJ; Kline AE; Bondi CO; Simon DW; Carlson SW; Puccio AM; Horvat CM; Au AK; Elmer J; Treble-Barna A; Ikonomovic MD; Shutter LA; Taylor DL; Stern AM; Graham SH; Kagan VE; Jackson EK; Wisniewski SR; Dixon CE
    J Neurotrauma; 2020 Nov; 37(22):2353-2371. PubMed ID: 30520681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects.
    Wei J; Xiao GM
    Acta Pharmacol Sin; 2013 Dec; 34(12):1485-90. PubMed ID: 24241345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Progesterone for Acute Traumatic Brain Injury: a Meta-analysis of Randomized Controlled Trials.
    Wang Z; Shi L; Ding W; Shao F; Yu J; Zhang J
    Mol Neurobiol; 2016 Dec; 53(10):7070-7077. PubMed ID: 26676571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.
    Chiu LS; Anderton RS; Knuckey NW; Meloni BP
    Mol Neurobiol; 2017 Dec; 54(10):7838-7857. PubMed ID: 27844291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone for Traumatic Brain Injury: A Meta-Analysis Review of Randomized Controlled Trials.
    Lu XY; Sun H; Li QY; Lu PS
    World Neurosurg; 2016 Jun; 90():199-210. PubMed ID: 26960278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.